FLUQUADRI (Sanofi-Aventis Australia Pty Ltd)
Product name
FLUQUADRI
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
178 working days (255)
Active ingredients
influenza virus haemagglutinin
Registration type
EOI
Indication
FLUQUADRI (suspension for injection) is indicated for active immunisation of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.
FLUQUADRI is now indicated for use in adults and children 6 months and older.